NDC 0067-2042 – Excedrin Migraine Relief

Acetaminophen 250 mg/1; Aspirin 250 mg/1; Caffeine 65 mg/1 · Tablet, Film Coated · Oral

Human Otc Drug

Product NDC0067-2042

Product details

Brand name
Excedrin Migraine Relief
Generic name
Acetaminophen, Aspirin (NSAID), Caffeine
Labeler
Haleon US Holdings LLC
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA020802
Marketed since
January 1, 2024
Listing expires
December 31, 2026
Pharmacologic class
Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Excedrin →

Package NDC codes (8)

Package NDCDescriptionSince
0067-2042-011 BOTTLE in 1 CARTON (0067-2042-01) / 24 TABLET, FILM COATED in 1 BOTTLEJan 1, 2024
0067-2042-021 BOTTLE in 1 CARTON (0067-2042-02) / 30 TABLET, FILM COATED in 1 BOTTLEJan 1, 2024
0067-2042-031 BOTTLE in 1 CARTON (0067-2042-03) / 50 TABLET, FILM COATED in 1 BOTTLEJan 1, 2024
0067-2042-041 BOTTLE in 1 CARTON (0067-2042-04) / 100 TABLET, FILM COATED in 1 BOTTLEJan 1, 2024
0067-2042-051 BOTTLE in 1 CARTON (0067-2042-05) / 125 TABLET, FILM COATED in 1 BOTTLEJan 1, 2024
0067-2042-061 BOTTLE in 1 CARTON (0067-2042-06) / 200 TABLET, FILM COATED in 1 BOTTLEJan 1, 2024
0067-2042-071 BOTTLE in 1 CARTON (0067-2042-07) / 250 TABLET, FILM COATED in 1 BOTTLEJan 1, 2024
0067-2042-08300 TABLET, FILM COATED in 1 BOTTLE (0067-2042-08)Jan 1, 2024

Other Excedrin products